NCT06319963 2026-02-02A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal CancerTheravectys S.A.Phase 1/2 Recruiting72 enrolled
NCT05312710 2026-01-16Safety and Efficacy of APG-157 in Head and Neck CancerAveta Biomics, Inc.Phase 2 Active not recruiting24 enrolled
NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT03589339 2025-10-24NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyNanobiotixPhase 1 Active not recruiting145 enrolled